Target intelligence / Profile preview

APC2 antisense RNA 1 (APC2-AS1)

Target
APC2-AS1
Molecular classification
Long non-coding RNA, Natural antisense transcript
01

Overview

APC2 antisense RNA 1 (APC2-AS1) refers to a predicted long non-coding antisense RNA transcribed from the opposite strand at the APC2 gene locus. Such antisense RNAs are known in general to modulate gene expression through transcriptional interference, chromatin modification, and epigenetic regulation, but there are no studies confirming the expression, functional role, or disease relevance of APC2-AS1 itself[2]. At present, APC2-AS1 is neither recognized as a therapeutic target nor as a characterized biomolecule, and its mention likely reflects annotation conventions rather than biological discovery. The lack of functional references, aliases, molecular function, or related drugs indicates that APC2-AS1 is probably a computationally annotated, but experimentally unvalidated, transcript. If you require information about the protein-coding APC2 gene, significant details exist regarding its roles in Wnt signaling, cytoskeleton regulation, neurodevelopment, and tumor suppression, but these do not apply directly to APC2-AS1[1][5].

02

Biological functions

Potential regulation of APC2 gene expression (inferred based on antisense transcript location; not experimentally confirmed)General antisense RNA mechanisms such as transcriptional interference, epigenetic modulation, and chromatin structure alteration

Beyond the preview

Go deeper on APC2 antisense RNA 1 (APC2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APC2 antisense RNA 1 (APC2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call